ANI Pharmaceuticals Inc. (ANIP) Fell To A 5-Month Low After Q3 Report

ANI Pharmaceuticals Inc. (ANIP) reported third quarter EPS of $1.09 Thursday morning, compared to $0.80 last year. The consensus estimate was for EPS of $1.08. The company expects to report full year EPS of $4.00 to $4.25. Street expectations are for EPS of $4.09.

from RTT - Before the Bell http://ift.tt/2f87c9V
via IFTTT